INTERIM REPORT 1 JANUARY – 31 MARCH, 2017
First quarter compared to 2016, Group » Group net sales increased by 12% to SEK 462,979 (411,834). » Other operating income amounted to SEK 71,902 (565,286). » Income after financial items amounted to SEK –19,036,869 (–11,696,747). » Earnings per share (weighted average) amounted to SEK –0.66 (–0.89). Significant events during the first quarter » Episurf Medical announced and conducted a rights issue and raised approximately SEK 109.5 M prior to transaction costs. » Episurf Medical is expanded its Clinical Advisory Board. » Dennis D. Stripe to act as executive